TMP-SMX superior in treating Toxoplasma encephalitis.
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D004660:Encephalitis / Q000188:drug therapy* / Q000469:parasitology; D006801:Humans; D011739:Pyrimethamine / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D013411:Sulfadiazine / Q000008:administration & dosage; D014123:Toxoplasmosis / Q000188:drug therapy*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D013411:Sulfadiazine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D011739:Pyrimethamine